Elective lung resection after treatment for COVID-19 pneumonia

Takashi Sakai, Yoko Azuma, Kotaro Aoki, Megumi Wakayama, Shion Miyoshi, Kazuma Kishi, Kazuhiro Tateda, Sakae Homma, Akira Iyoda, Takashi Sakai, Yoko Azuma, Kotaro Aoki, Megumi Wakayama, Shion Miyoshi, Kazuma Kishi, Kazuhiro Tateda, Sakae Homma, Akira Iyoda

Abstract

A 65-year-old man with coronavirus disease 2019 (COVID-19) was admitted to our hospital. Computed tomography detected bilateral pneumonia with a lung nodule suspicious for lung cancer. Lobectomy was performed 3 months after the treatment for COVID-19 without any complications. The surgical specimen revealed fibrosis below the pleura with a small collection of lymphocytes and intravascular hemorrhagic thrombosis, and no residual RNA was detected. This is the first report describing a surgical specimen after recovery from COVID-19 pneumonia, and suggests that elective thoracic surgery can be performed safely, depending on the patient's respiratory function, without infectious risk.

Keywords: COVID-19; Lung cancer; SARS-CoV-2.

Figures

Fig. 1
Fig. 1
a, b The computed tomography scan on admission showed patchy consolidation with ground grass opacity in all lung lobes and a solid nodule (arrow). The consolidation worsened 2 weeks (c), and improved d 6, e 10, and f 16 weeks after admission, however, subpleural curvilinear shadow of the right lower lobe remained 16 weeks after admission (arrows)
Fig. 2
Fig. 2
Time table, and inspection and d-dimer value results of the patient. His oxygenation evaluated using the saturation of percutaneous and arterial oxygen improved, and the pulmonary function test improved markedly from 6 to 12 and 16 weeks after admission. The d-dimer value was high during the infection, and returned to the normal level before surgery
Fig. 3
Fig. 3
af Histologically, subpleural fibrosis in the alveolar wall (arrows) was widely observed (a: Hematoxylin–Eosin staining, Scale bar = 500 µm, b: Elastica van Gieson stain, Scale bar = 200 µm) and focally along the alveolar septum (c: Hematoxylin–Eosin staining, Scale bar = 500 µm, d Elastica van Gieson stain, Scale bar = 200 µm). e Infiltration of inflammatory cells including neutrophils, lymphocytes, plasma cells and eosinophils was partially observed (Hematoxylin–Eosin staining, Scale bar = 100 µm). f Organized hemorrhagic thrombosis were found in peripheral pulmonary vessels (Elastica van Gieson stain, Scale bar = 200 µm)

References

    1. Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, Carrott P, et al. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. Ann Thorac Surg. 2020;110:692–696. doi: 10.1016/j.athoracsur.2020.03.005.
    1. Nepogodiev D, Bhangu A, Glasbey JC, Li E, Omar OM, Simoes JF, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396:27–38. doi: 10.1016/S0140-6736(20)31182-X.
    1. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–704. doi: 10.1016/j.jtho.2020.02.010.

Source: PubMed

3
Iratkozz fel